Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a survival tree begins...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Context-aware simulation enables systematic optimization of long-read mapping parameters.

GigaScience·2026
Same author

Digital literacy is associated with college students' learning engagement via sequential mediation of self-efficacy and learning adaptability.

Scientific reports·2026
Same author

Super learner model for predicting carotid plaque regression in type 2 diabetes on PCSK9 inhibitors.

Acta diabetologica·2026
Same author

Identification of cardiovascular disease in patients with kidney stone disease using explainable machine learning.

Frontiers in cardiovascular medicine·2026
Same author

Growth differentiation factor-15 and the incidence, bidirectional progression, and risk prediction of atherosclerotic cardiovascular disease and metabolic dysfunction-associated steatotic liver disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3.

Cardiovascular diabetology·2026
Same author

Research on Carotid Blood Flow Detection Based on Interferometric Diffuse Speckle Contrast Analysis and Its Application in Preventing Ischemic Stroke.

Journal of biophotonics·2026

Related Experiment Video

Updated: Jul 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Yingli Pan1, Yinfei Guo1, Chentao Yang1

  • 1Hubei Key Laboratory of Applied Mathematics, Faculty of Mathematics and Statistics, Hubei University, Wuhan, China.

Statistics in Medicine
|July 7, 2026
PubMed
Summary

This study introduces a parameter transfer learning method to improve treatment effect estimation for right-censored survival data. The approach enhances prediction accuracy and robustness, aiding personalized medicine decisions.

Keywords:
greedy algorithmindividualized treatment ruleright‐censored survival datatransfer learning

Related Experiment Videos

Last Updated: Jul 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Area of Science:

  • Biostatistics
  • Machine Learning
  • Personalized Medicine

Background:

  • Accurate estimation of treatment effects is vital for personalized medicine.
  • Right-censored survival data presents significant challenges in treatment effect estimation.
  • Existing methods may lack robustness and accuracy with complex, heterogeneous data.

Purpose of the Study:

  • To propose a novel parameter transfer learning method for estimating treatment effects on right-censored survival data.
  • To leverage multi-source auxiliary data to improve prediction accuracy and model robustness.
  • To provide a statistically sound and computationally efficient approach for clinical decision-making.

Main Methods:

  • Parameter transfer learning framework utilizing multi-source auxiliary data.
  • Construction of source models by extracting shared parameters.
  • Estimation of candidate model parameters using a smoothed concordance index for right-censored data.
  • Optimization of model averaging weights via leave-one-out cross-validation.

Main Results:

  • Theoretical guarantees of asymptotic optimality and model weight consistency under specified conditions.
  • Simulation studies demonstrating reduced bias and enhanced prediction accuracy, especially for right-censored and heterogeneous data.
  • Successful application to the SUPPORT (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) extension dataset (support2).

Conclusions:

  • The proposed parameter transfer learning method effectively enhances treatment effect estimation for right-censored survival data.
  • The method offers improved accuracy and robustness, showing significant potential for personalized clinical decision-making.
  • This approach addresses key challenges in survival data analysis within personalized medicine.